Core Viewpoint - The company, 信铭生命科技, has acknowledged the findings of the Securities and Futures Commission regarding its shareholding structure, indicating a significant concentration of ownership among a small number of shareholders [1] Group 1: Shareholding Structure - As of December 31, 2025, twenty shareholders and their associates collectively held 1.387 billion shares, representing 18.79% of the total issued shares [1] - The three major shareholders own 5.31 billion shares, accounting for 71.94% of the total issued shares, leading to a total of 90.73% of shares held by these shareholders [1] - Only 684 million shares, or 9.27% of the total issued shares, are held by other shareholders [1] Group 2: Share Price Movement - The closing price of the shares increased by 489% from HKD 0.019 on September 10, 2025, to HKD 0.112 on December 31, 2025 [1] - On January 12, 2026, the share price closed at HKD 0.118, reflecting a 521% increase compared to the closing price of HKD 0.019 on September 10, 2025 [1] Group 3: Public Shareholding Compliance - The company confirms that at least 25% of its issued shares are held by the public as of December 31, 2025, and on the date of the announcement, ensuring compliance with the public float requirements of the stock exchange [2]
信铭生命科技(00474)回应股权高度集中，称公司能遵守公众持股量规定